Table 1 Initial and true (final) lytA-positive samples per serotypes/serogroup after subtraction of false positivity (bold).

From: Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule

Serotypes/serogroup

Rate of positivity initially revealed in lytA-positive samples (%)

Rate of false positivity revealed in lytA-negative samples that had to be subtracted (%)

Rate of true positivity (%)

1

1.5

0.0

1.5

2

0.8

0.0

0.8

3

4.2

0.0

4.2

6A/B/C/D

1.4

0.0

1.4

7A/F

0.0

0.0

0.0

8

0.5

0.0

0.5

9A/L/N/V

2.5

0.0

2.5

10A/B

4.1

0.0

4.1

12A/B/F/44/46

1.5

0.0

1.5

13

0.0

0.0

0.0

14

0.0

0.0

0.0

16F

1.2

0.0

1.2

17F

0.5

0.0

0.5

19A

4.4

0.0

4.4

19F

3.1

0.0

3.1

20

1.7

0.0

1.7

21

5.9

0.0

5.9

22A/F

3.4

0.0

3.4

23A

6.6

0.0

6.6

23B

11.0

0.0

11.0

23F

0.0

0.0

0.0

29

0.0

0.0

0.0

33F

3.1

0.0

3.1

35B/D

4.8

0.0

4.8

35F/37

7.3

0.0

7.3

38/25A/F

4.6

0.0

4.6

7B/C

3.6

1.0

2.6

11A/D/E

14.4

3.0

11.4

15A/B/C/F

14.8

1.0

13.8

31

4.8

1.0

3.8